17 results
8-K
EX-10.20
QLGN
Qualigen Therapeutics Inc
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
and implementation; (ff) improvement in workforce diversity; (gg) customer indicators; (hh) new product invention or innovation; (ii) attainment
424B3
QLGN
Qualigen Therapeutics Inc
9 Apr 20
Prospectus supplement
9:30am
announced that Ritter was conducting a review of a range of strategic alternatives. In addition, Ritter began a process to reduce its workforce, general
S-4/A
m7yuian81r9p
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
CORRESP
7t0i4h
13 Mar 20
Correspondence with SEC
12:00am
S-4
0k3iddl7
4 Feb 20
Registration of securities issued in business combination transactions
6:26am
10-K
b93yl a21piv
21 Mar 16
Annual report
12:00am
10-Q
hwx ohe6ya
12 Aug 15
Quarterly report
12:00am
DRS
7ytd6rxx
29 Jan 15
Draft registration statement
12:00am
- Prev
- 1
- Next